The first double-blind randomized placebo-controlled phase 2 study to assess the efficacy and safety of insulin sensitizer in patients with non-alcoholic steatohepatitis in Asia- an interim report

被引：0
|
作者：
Yeh, Ming-Lun [1 ,2 ]
Huang, Chung-Feng [1 ,2 ,3 ]
Tsai, Pei-Chien [2 ]
Huang, Ching-I [1 ,2 ,3 ]
Dai, Chia-Yen [1 ,2 ,3 ]
Chen, Shinn-Chern [1 ,2 ]
Huang, Jee-Fu [1 ,2 ,3 ,4 ,5 ]
Yu, Ming-Lung [1 ,2 ,4 ,5 ]
Chuang, Wan-Long [1 ,2 ]
机构：
[1] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Grad Inst Clin Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Ctr Liquid Biopsy, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ Hosp, Canc Res Ctr, Kaohsiung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI101
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [41] The liver fibroinflammatory marker cT1 is reduced with aldafermin therapy in a randomized, double-blind, placebo-controlled, multicenter study in patients with non-alcoholic steatohepatitis
    Paredes, Angelo
    Ling, Lei
    Banerjee, Rajarshi
    Guy, Cynthia
    Frias, Juan
    Younes, Ziad H.
    Trotter, James F.
    Gunn, Nadege T.
    Kohli, Anita
    Nelson, Kristen
    Gottwald, Mildred
    Chang, William
    Yan, Andrew
    DePaoli, Alex
    Lieu, Hsiao
    Harrison, Stephen
    JOURNAL OF HEPATOLOGY, 2021, 75 : S410 - S415
  • [42] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [43] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF DOXERCALCIFEROL IN VITAMIN D-REPLETE CKD PATIENTS
    Patel, Anita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A60 - A60
  • [44] Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
    Loomba, Rohit
    Lawitz, Eric J.
    Frias, Juan Pablo
    Ortiz-Lasanta, Grisell
    Johansson, Lars
    Franey, Bridgette Boggess
    Morrow, Linda
    Rosenstock, Moti
    Hartsfield, Cynthia L.
    Chen, Chao-Yin
    Tseng, Leo
    Charlton, R. Will
    Mansbach, Hank
    Margalit, Maya
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (02): : 120 - 132
  • [45] A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActiveTM) for COVID-19 Patients
    Majeed, Muhammed
    Nagabhushanam, Kalyanam
    Shah, Kalpesh
    Mundkur, Lakshmi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [46] Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
    Nobuya Inagaki
    Shin-ichi Harashima
    Nobuko Maruyama
    Yutaka Kawaguchi
    Maki Goda
    Hiroaki Iijima
    Cardiovascular Diabetology, 15
  • [47] Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
    Inagaki, Nobuya
    Harashima, Shin-ichi
    Maruyama, Nobuko
    Kawaguchi, Yutaka
    Goda, Maki
    Iijima, Hiroaki
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [48] A randomized, double-blind, placebo-controlled study to evaluate the efficacy of a multispecies probiotic mixture in obese non-alcoholic fatty liver disease
    Ahn, S. B.
    Jun, D. W.
    Saeed, W. K.
    Lee, J. S.
    Chae, Y. J.
    Oh, H. W.
    Jeong, J. Y.
    Kang, H. T.
    Jang, E. C.
    Kang, B. -K.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S592 - S592
  • [49] The leukotriene receptor antagonist montelukast in the treatment of non-alcoholic steatohepatitis: A proof-of-concept, randomized, double-blind, placebo-controlled trial
    Abdallah, Mahmoud Samy
    Eldeen, Ahmed Hossam
    Tantawy, Sally Said
    Mostafa, Tarek Mohamed
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906
  • [50] A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of topiramate controlled release in the treatment of obese type 2 diabetic patients
    Rosenstock, Julio
    Hollander, Priscilla
    Gadde, Kishore M.
    Sun, Xiang
    Strauss, Richard
    Leung, Albert
    DIABETES CARE, 2007, 30 (06) : 1480 - 1486
12345